Specifica, a Q2 Solutions company, is applying its proven platform for antibody discovery to generate recombinant monoclonal antibody reagents. Our in vitro display approach eliminates the need for...
ImmunXperts, a Q2 Solutions company, provides functional insights into immune-mediated adverse events. We provide in silico and in vitro methods, using T-cell activation and proliferation as a...
In examining two-group differential analysis, it is apparent that different statistical methods can yield very different results even given the same RNA-Seq input data. In particular, we have...
With more than 25 years of experience, Rules-Based Medicine, a Q2 Solutions company develops, validates and manufactures its assays with integrity and commitment for the most reliable, reproducible...
By Chloe Ackaert, Jana Schockaert, Aurelie Mazy, Martijn Vlaming, and Sofie PattynPresented at the American Association for Cancer Research (AACR) Annual Meeting, April 5-10, 2024 Bispecifics...